Story perspectives

Over 140,000 Atorvastatin Tablets Recalled for Quality Issues

11/7/2025

39 3

Summary

Story summary

More than 140,000 atorvastatin calcium tablets were recalled after Ascend Laboratories, LLC initiated the action on September 19 due to a quality issue.
The U.S. Food and Drug Administration classified the recall as Class II, indicating a small risk of temporary health issues.
Consumers should check bottles manufactured by Alkem Laboratories, Ltd.
If affected, patients should consult a pharmacist for replacements because discontinuing the medication may pose greater health risks.

1 of 1

Story summary

More than 140,000 atorvastatin calcium tablets were recalled after Ascend Laboratories, LLC initiated the action on September 19 due to a quality issue.
The U.S. Food and Drug Administration classified the recall as Class II, indicating a small risk of temporary health issues.
Consumers should check bottles manufactured by Alkem Laboratories, Ltd.
If affected, patients should consult a pharmacist for replacements because discontinuing the medication may pose greater health risks.